Have your own idea? Try our Stock Screener
In the last week, the Healthcare industry is flat overall, with Neurocrine Biosciences standing out by going down 17%. The past year has been better, since the industry has gained 14% in that time. Looking forward, earnings are forecast to grow by 22% annually.
Has the U.S. Healthcare Sector valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 31 Aug 2024 | US$6.3t | US$2.8t | US$54.1b | 32.3x | 116.2x | 2.2x |
Mon, 29 Jul 2024 | US$6.4t | US$2.8t | US$60.8b | 31.7x | 105x | 2.2x |
Wed, 26 Jun 2024 | US$6.2t | US$2.8t | US$62.4b | 30.3x | 99.7x | 2.2x |
Fri, 24 May 2024 | US$6.2t | US$2.8t | US$64.3b | 30.2x | 97x | 2.2x |
Sun, 21 Apr 2024 | US$5.9t | US$2.8t | US$84.6b | 30.2x | 70.1x | 2.1x |
Tue, 19 Mar 2024 | US$6.2t | US$2.8t | US$84.7b | 31.5x | 73.4x | 2.2x |
Thu, 15 Feb 2024 | US$6.1t | US$2.8t | US$82.0b | 31.1x | 74.6x | 2.2x |
Sat, 13 Jan 2024 | US$6.4t | US$2.8t | US$90.8b | 32.2x | 70.2x | 2.3x |
Mon, 11 Dec 2023 | US$6.0t | US$2.8t | US$91.4b | 29.4x | 65.2x | 2.1x |
Wed, 08 Nov 2023 | US$5.8t | US$2.8t | US$86.9b | 25.8x | 66.6x | 2.1x |
Fri, 06 Oct 2023 | US$5.8t | US$2.8t | US$98.3b | 26.7x | 59.1x | 2.1x |
Sun, 03 Sep 2023 | US$6.1t | US$2.8t | US$98.7b | 27.4x | 61.9x | 2.2x |
Tue, 01 Aug 2023 | US$6.1t | US$2.7t | US$115.7b | 28x | 52.5x | 2.2x |
Thu, 29 Jun 2023 | US$6.0t | US$2.7t | US$109.9b | 26.3x | 54.2x | 2.2x |
Sat, 27 May 2023 | US$5.8t | US$2.7t | US$110.5b | 24.4x | 52.6x | 2.1x |
Mon, 24 Apr 2023 | US$6.0t | US$2.5t | US$117.6b | 24.9x | 51x | 2.4x |
Wed, 22 Mar 2023 | US$5.7t | US$2.5t | US$124.2b | 23.4x | 45.9x | 2.3x |
Fri, 17 Feb 2023 | US$5.9t | US$2.5t | US$130.3b | 24.5x | 45.1x | 2.4x |
Sun, 15 Jan 2023 | US$6.1t | US$2.5t | US$135.9b | 22.9x | 44.6x | 2.5x |
Tue, 13 Dec 2022 | US$6.1t | US$2.4t | US$133.7b | 23.7x | 45.9x | 2.5x |
Thu, 10 Nov 2022 | US$5.8t | US$2.4t | US$136.7b | 22.5x | 42.2x | 2.4x |
Sat, 08 Oct 2022 | US$5.5t | US$2.4t | US$155.8b | 21.4x | 35.5x | 2.3x |
Mon, 05 Sep 2022 | US$5.7t | US$2.4t | US$156.6b | 22.2x | 36.2x | 2.4x |
Wed, 03 Aug 2022 | US$6.0t | US$2.6t | US$165.6b | 24.1x | 36x | 2.3x |
Fri, 01 Jul 2022 | US$5.8t | US$2.6t | US$165.9b | 23.6x | 34.9x | 2.2x |
Sun, 29 May 2022 | US$6.0t | US$2.6t | US$165.6b | 25.5x | 36.3x | 2.3x |
Tue, 26 Apr 2022 | US$6.3t | US$2.5t | US$174.7b | 27.9x | 35.8x | 2.5x |
Thu, 24 Mar 2022 | US$6.4t | US$2.5t | US$170.6b | 28.3x | 37.3x | 2.6x |
Sat, 19 Feb 2022 | US$6.1t | US$2.5t | US$166.0b | 28.7x | 36.7x | 2.5x |
Mon, 17 Jan 2022 | US$6.5t | US$2.4t | US$145.0b | 31.5x | 44.5x | 2.7x |
Wed, 15 Dec 2021 | US$6.7t | US$2.4t | US$146.1b | 31x | 45.7x | 2.8x |
Fri, 12 Nov 2021 | US$6.8t | US$2.4t | US$146.6b | 34.4x | 46.5x | 2.8x |
Sun, 10 Oct 2021 | US$6.6t | US$2.3t | US$118.8b | 34.7x | 55.2x | 2.8x |
Tue, 07 Sep 2021 | US$7.0t | US$2.3t | US$119.6b | 30.1x | 58.7x | 3x |
58.7x
Which industries have driven the changes within the U.S. Healthcare sector?
US Market | 0.056% | |
Healthcare | 0.90% | |
Healthtech | 4.22% | |
Medical Equipment | 1.21% | |
Pharma | 1.10% | |
Healthcare Services | 0.78% | |
Life Sciences | 0.73% | |
Biotech | 0.10% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LLY Eli Lilly | US$960.02 | 0.8% +US$6.6b | 72.3% | PE117.7x | |
UNH UnitedHealth Group | US$590.20 | 1.0% +US$5.3b | 23.9% | PE38.6x | |
MRK Merck | US$118.45 | 1.6% +US$4.7b | 7.8% | PE21.9x | |
JNJ Johnson & Johnson | US$165.86 | 1.1% +US$4.2b | 3.4% | PE24.4x | |
BSX Boston Scientific | US$81.79 | 3.3% +US$3.9b | 52.5% | PE65.9x |